cbdMD Reports Q3 Net Sales Increase 42% Sequentially to Over $8 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
cbdMD, Inc. (YCBD) Reports Q3 Loss of $1.19; Offers FY19 & FY20 Sales Guidance
August 14, 2019 4:24 PM EDTcbdMD, Inc. (NYSE: YCBD) reported Q3 EPS of ($1.19), versus $0.03 reported last year. Revenue for the quarter came in at $9.78 million, versus $1.85 million reported last year.
Our strong third quarter results place us in a great position to exceed established revenue targets for the first year of operations for cbdMD, stated Martin A. Sumichrast, Chairman and co-CEO of cbdMD. Moreover, we believe we are now on track to reach the five-year earn-out hurdle of $300 million in aggregate net revenue by the end of calendar 2021, full two years ahead of schedule.
Weve... More
